Schedule 13G ownership disclosure

Ovid therapeutics, Inc.

Common Stock, par value $0.001 per share · CUSIP: 690469101

Event date: 2025-12-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Affinity Asset Advisors, LLC

    Shares: 12,149,166 · Class: 9%

  • Affinity Healthcare Fund, LP

    Shares: 12,149,166 · Class: 9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001315863-25-000859
Form type
SCHEDULE 13G
Filer
Affinity Asset Advisors, LLC
CIK
CIK 1773195
Filed
Dec 18, 2025
Reporting period
Dec 11, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub